CLBIO.STCLBIO.STSTO
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -67.78% | -45.02% | -3.02% | -26.27% | +4.57% |
| Gross Profit Growth | +0.00% | +0.00% | -62.65% | -39.94% | -450.38% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +5.98% | +13.96% | +13.96% | +13.96% | +11.81% |
| Weighted Average Shares Diluted Growth | +5.98% | +13.96% | +13.96% | +13.96% | +11.81% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -339.10% | -351.83% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | -52058.33% | -1354.23% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -61.25% | +1.66% | -37.36% | +71.58% | -12.29% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -5.34% | -11.49% | -14.58% | -11.53% | +4.03% |
| Book Value per Share Growth | -12.12% | -19.72% | -19.19% | -19.81% | -3.52% |
| Debt Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -17.57% | -27.08% | +0.00% | -100.00% | -100.00% |